Health ❯Public Health ❯Vaccines ❯COVID-19 Vaccines

FDA Approval Process

FDA Restricts Moderna and Novavax COVID-19 Vaccines to Seniors and Vulnerable Groups

He argued falling COVID-19 severity means even rare side effects could outweigh benefits for younger, healthier people.

FDA Shifts COVID-19 Vaccine Policy to Focus on High-Risk Groups

FDA Appoints Vaccine Critic Vinay Prasad as New Biologics Chief